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Haplotype-based association analysis has been recognized as a tool with high resolution and potentially great power
for identifying modest etiological effects of genes. However, in practice, its efﬁcacy has not been as successfully
reproduced as expected in theory. One primary cause is that such analysis tends to require a large number of
parameters to capture the abundant haplotype varieties, and many of those are expended on rare haplotypes for
which studies would have insufﬁcient power to detect association even if it existed. To concentrate statistical power
on more-relevant inferences, in this study, we developed a regression-based approach using clustered haplotypes to
assess haplotype-phenotype association. Speciﬁcally, we generalized the probabilistic clustering methods of Tzeng
to the generalized linear model (GLM) framework established by Schaid et al. The proposed method uses unphased
genotypes and incorporates both phase uncertainty and clustering uncertainty. Its GLM framework allows adjust-
ment of covariates and can model qualitative and quantitative traits. It can also evaluate the overall haplotype
association or the individual haplotype effects. We applied the proposed approach to study the association between
hypertriglyceridemia and the apolipoprotein A5 gene. Through simulation studies, we assessed the performance of
the proposed approach and demonstrate its validity and power in testing for haplotype-trait association.
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In the search for genes underlying human complex dis-
eases, one crucial step is to detect the association be-
tween the genetic variants and the disease phenotypes.
Since a high density of SNPs is being identiﬁed and used
in genetic studies, jointly analyzing all variants within a
gene or chromosomal region for association can be more
informative and effective (Stephens et al. 2001). The
haplotype, the ordered allele sequences on a chromo-
some, provides a natural framework for performing joint
analysis of multiple markers and is predominantly con-
sidered the unit of analysis in association studies. Hap-
lotype analyses are believed to provide high resolution
and potentially great power for identifying modest etio-
logical effects of genes (International HapMap Consor-
tium 2003). Following this viewpoint, many statistical
methods have been proposed to evaluate haplotype-dis-
ease association for case-control samples, including like-
lihood ratio tests for testing equality of haplotype fre-
quencies between cases and controls (e.g., Sham 1998),
tests and inferences for speciﬁc haplotype effects under
a variety of regression models (e.g., Schaid et al. 2002;
Zaykin et al. 2002; Epstein and Satten 2003; Lake et
al. 2003; Stram et al. 2003; Zhao et al. 2003; Lin 2004;
Zeng and Lin 2005), haplotype-similarity approaches
that detect association via excessive haplotype sharing
in cases (e.g., Van der Meulen and te Meerman 1997;
McPeek and Strahs 1999; Bourgain et al. 2000, 2001,
2002; Tzeng et al. 2003a, 2003b; Yu et al. 2004), and
clustering methods that group homogeneous haplotypes
and perform analysis on the unit of haplotype groups
(e.g., Seltman et al. 2001, 2003; Molitor et al. 2003a,
2003b; Durrant et al. 2004; Tzeng 2005).
Whereas the progress in both data availability and
data analyses increases the feasibility of haplotype-based
association studies, practical implementation indicates
that the study ﬁndings of such types are not consistently
reproducible (Lohmueller et al. 2003; Neale and Sham
2004). Lohmueller et al. (2003) concluded that the in-
consistency could be explained largely by a high rate of
false-negative results or, equivalently, lack of power. Re-
cently, Chapman and colleagues (Chapman et al. 2003;
Clayton et al. 2004) further revealed that analyses-based
locus models that regress phenotypes on multiple SNP
loci can sometimes be more powerful than haplotype
analyses, such as when tag SNPs are used. The main rea-
son is that the locus model uses fewer parameters than
does a haplotype model; by modeling only the main effect
and low-order interactions of SNPs, the locus model
does not spend degrees of freedom on rare haplotypes
for which studies would have insufﬁcient power to detect
association even if it were present (Clayton et al. 2004).
In contrast to a locus model, haplotype analysis re-
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quires a larger number of parameters to capture the
abundant haplotype varieties, and the test power is lim-
ited by the many degrees of freedom that they use. The
power is worsened by the need to adjust for multiple
testing when many genes are evaluated. Further difﬁ-
culties emerge from the fact that complex diseases are
derived from intricate genetic and environmental factors
(see, e.g., Peltonen and McKusick 2001). Understanding
the genetic etiology of complex diseases requires a joint
consideration of all potential attributes and sometimes
even other auxiliary covariates. The vast quantities of
covariates from environmental effects and gene-gene and
gene-environment interactions further exacerbate the de-
grees-of-freedom problem.
Model-based association methods, which incorporate
covariate information in association analysis, play an
increasingly important role in modern association stud-
ies. They facilitate the study of complex gene-disease as-
sociation. Besides the ability to accommodate polygenic
effects, environmental covariates, and interactions among
them, model-based analyses can evaluate haplotype ef-
fects at either the global level (i.e., evaluating overall
haplotype association) or the individual level (i.e., eval-
uating haplotype-speciﬁc association). They also allow
modeling of diseases through a variety of clinical phe-
notypes, from dichotomous to ordinal to quantitative
traits. These ﬂexibilities and advantages again reﬂect the
need for efﬁcient usage of haplotype information in a
model-based framework for studying association.
Haplotype grouping offers one promising avenue for
controlling the issue of degrees of freedom that is en-
countered in haplotypes-based multiple-marker analysis.
It enhances the efﬁciency of haplotype analysis by using
a small number of degrees of freedom to study haplo-
types and concentrates statistical power on more-rele-
vant inference. In an earlier study (Tzeng 2005), we in-
troduced an algorithm to cluster related haplotypes to
improve the power of association tests. This algorithm
adapts the same evolutionary concepts of cladistic anal-
yses and groups rare haplotypes with their closest major
haplotypes according to the evolutionary relationships
summarized in a haplotype tree. Since many haplotype
trees are often virtually likely given the observed data,
one key feature of the proposed algorithm is the incor-
poration of the tree uncertainty in association testing.
The algorithm is motivated by and relies on the com-
mon disease/common variants assumption (Collins et al.
1997), which conjectures that common modest-risk var-
iants may contribute more to the development of com-
mon complex disease than do rare high-risk variants. The
algorithm is also built on the recent discovery of the
human genome structure that the majority of haplotype
diversities are concentrated on a few major categories
because of the correlations among proximate SNPs (e.g.,
Daly et al. 2001; Johnson et al. 2001). Therefore, instead
of spending degrees of freedom on rare haplotypes that
would result in unstable statistical inference and insuf-
ﬁcient testing power, the algorithm reduces the observed
haplotype space, in a probabilistic manner, to a core
haplotype set that contains fewer polymorphisms but
possesses the essential information for studying haplo-
type-disease association. Such core haplotype diversity
presumably mimics the diversity before the occurrence
of other events that are not directly related to the evo-
lution of disease mutation—for example, recent marker
mutation, gene conversion, genotyping error, and even
missing data.
The grouping analysis of Tzeng (2005) is limited to
assessing global association between haplotypes and
traits. It cannot evaluate the effect of individual haplo-
types or accommodate for covariates. Its implementation
requires phased haplotypes and empirical evaluation of
the signiﬁcance level. In the present study, we generalized
the clustering approach of Tzeng (2005) to a generalized
linear model framework and allowed for unphased ge-
notypes. We constructed tests that are based on clustered
haplotypes, for assessing association at both global and
haplotype-speciﬁc levels. The test incorporates two ma-
jor sources of uncertainties in haplotype analysis—clus-
tering uncertainty and phase uncertainty. Among the
many promising regression-based approaches that eval-
uate individual effects of haplotypes through use of ge-
notypes, we established our work on the score tests de-
veloped by Schaid et al. (2002). Their method has been
shown to be robust to departure from the Hardy-Wein-
berg equilibrium and to possess comparable power with
retrospective approaches for case-control data that are
sampled retrospectively (Satten and Epstein 2004).
Through simulation studies, we assessed the performance
of the proposed approach and demonstrated its validity
and power in testing for haplotype-trait association. We
also illustrated the proposed approach through an appli-
cation to a hypertriglyceridemia study, in which we tested
the apolipoprotein A5 gene (APOA5), a conﬁrmed risk
factor of hypertriglyceridemia.
Methods
We begin this section by reviewing the clustering methods of
Tzeng (2005). We then integrate the clustering algorithm into
a regression framework. Finally, we construct the score test
for association that incorporates phase ambiguity and clus-
tering uncertainty on the basis of the work of Schaid et al.
(2002) and Tzeng (2005).
The Haplotype-Clustering Method of Tzeng
The fundamental purpose of the clustering algorithm is to
group rare haplotypes with their corresponding ancestral hap-
lotypes. Given an evolutionary tree of haplotypes, the algo-
rithm sequentially combines “rare” haplotypes into their one-
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step neighboring haplotypes, from the tips of the tree toward
the major nodes. Each of the resulting clusters is represented
by the most common haplotype, and haplotypes within a clus-
ter are assumed to have the same effect on the disease trait.
Determining “rare” haplotypes requires a trade-off between
information and dimensionality, and the algorithm uses an in-
formation criterion to ﬁnd the optimal balance between the
two. The information criterion is deﬁned as “the cumulative
Shannon information content” (Shannon 1948), with penalty
function determined by the number of dimensions and the
sample size involved. Denote HF as the full set of observed
haplotypes and HC as the set of clustered haplotypes. The
algorithm obtains HC by preserving high-frequency haplo-
types—that is, to set HC as the most frequent haplotypes,
where maximizes the information criterion.
In reality, the evolutionary tree is often unknown and needs
to be inferred. Instead of inferring the most-likely tree relation-
ship and performing grouping accordingly, the algorithm as-
signs each relationship branch a probability. It then clusters
haplotypes by considering all relationships according to the
probability weights. The branch probability is determined by
two factors that were commonly considered in reconstructing
a haplotype tree (Crandall and Templeton 1993; Slatkin and
Rannala 1997): (1) the relatedness of haplotypes and (2) the
age of haplotypes. The algorithm uses haplotype frequencies
to indicate the haplotype age. To measure the relatedness of
haplotypes, a certain metric of haplotype similarity is used,
such as counting the number of matching loci between two
haplotypes. When the evolutionary relationships are known,
the branch probability is reduced to an indicator function of
whether two haplotypes u and v are one-step related. For fur-
ther detail, see Tzeng (2005).
The general algorithm can be described as follows: ﬁrst,
partition the list HF into (1) , the core category, (2)
(0)H p HC
, the one-step neighbors of that consist of haplotypes(1) (0)H H
different from the core haplotypes by one step of mutation,
and (3) , the two-step neighbors of that consist of(2) (0)H H
haplotypes different from the core haplotypes by two steps of
mutation, and continue until the entire space of HF is ex-
hausted. Let denote the haplotype frequencies of HF; cor-PF
respondingly, is also decomposed into P(0),P(1),…,P(j),…,P(J).PF
Starting from to , group each element of to its(j)j p J j p 1 H
one-step ancestor in and combine the frequencies. The(j1)H
grouping rule is speciﬁed according to the branch probabilities
that are stored in the allocation matrix ; each row of(j) (j)B B
describes to whom and how a certain haplotype of is(j)H
allocated among . As illustrated by Tzeng (2005), this(j1)H
one-step grouping process is equivalent to the matrix operation
, and the overall process can be described as(j)′ (j)P B
′ (0)∗′ (0)′ (1)′ (1)P (p P ) p P P BC
(2)′ (2) (1) (J)′ (J) (J1) (2) (1)… …P B B  P B B B B .
Or, equivalently,
′ ′P p P B , (1)C F
where
(0)P I⎡ ⎤ ⎡ ⎤
(1) (1)P B
P p B p .F (2) (2) (1)P B B⎢ ⎥ ⎢ ⎥
_ _⎣ ⎦ ⎣ ⎦
Suppose there are distinct haplotypes in the population(L 1)
and they are clustered into groups. The dimension of∗(L  1)
is .∗B (L 1)# (L  1)
Regression Model with Clustered Haplotypes
Given that the clustering procedure can be implemented via
the matrix multiplication in equation (1), it is straightforward
to integrate this dimension reduction procedure into a regres-
sion framework. Under the regression model, probabilistic
clustering of haplotypes can be done by replacing the vector
of the haplotype frequencies P in equation (1) with the data
matrix of haplotypes. That is, denote XF as the haplotype ma-
trix of the full dimension with use of a certain scoring rule;
its entry, for example, can be the number of copies of(h,i)
haplotype h that individual i possesses. The matrix XF has
dimension , where n is the sample size. Then the(L 1)# n
data matrix of clustered haplotypes, XC, can be obtained by
′ ′X p X B(P) . (2)C F
Here, we rewrite the allocation matrix as to emphasizeB B(P)
the fact that the allocation matrix is a function of the hap-B
lotype frequency P.
Let Y denote an vector of the disease trait values, andn # 1
let denote a matrix of the P environmental covariates.Z P # n
With the original haplotype data of full dimension, the effects
of the genetic and environmental covariates can be modeled
by the generalized linear model (GLM):
′ ′g(EY) { h p X b Z g ,F F
where is an vector. The′ …b p (b ,b , ,b ) (L 1)# 1F F(0) F(1) F(L)
association of haplotypes with the disease traits can be detected
by testing …H :b p b p p b .0 F(0) F(1) F(L)
To reduce the degrees of freedom, we performed an analysis
on groups of homogeneous haplotypes, using the following
model:
′ ′g(EY) { h p X b Z g ,C C
where is obtained by the clustering algorithm of equation′XC
(2) and , , , with . The association′ ∗…b p (b b b ) L  L∗C C(0) C(1) C(L )
test is now performed through the parameters of the∗(L  1)
clustered haplotypes,
…H :b p b p p b . (3)∗0 C(0) C(1) C(L )
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Score Test Incorporating Clustering Uncertainty and Phase
Uncertainty
Here, we derive the score test for association in the clustered
haplotype space. We ﬁrst calculate the score function, which
is the partial derivative of the log likelihood function, and then
use it to construct the score test. To facilitate derivation, we
reparameterize via a linear transformationbC
…⎡ ⎤m 1 0 0⎡ ⎤
ma m 11b { p A , with A p .C [ ]_ a _ I ∗ ∗⎢ ⎥⎢ ⎥ L #L
ma 1∗⎣ ⎦ ⎣ ⎦L
Consequently, the global null hypothesis (3) is equivalent to
, and the effect of haplotype h can…H :a p a p p a p 0∗0 1 2 L
be examined by .H :a p 00 h
Consider observed data in which is the data ma-(Y,G,Z) G
trix of unphased genotypes. For each individual i, we treat the
observed genotype as an incomplete version of haplotypegi
count , which is the ith column of the design matrix .x XF,i F
Without losing generality, here we assume that the vector isxF,i
normed so that its entries sum to 1. Under the assumption
of Hardy-Weinberg equilibrium, ultinomial .1x ∼ #m (2,P )F,i F2
The GLM density of trait , given covariates and , isy x zi F,i i
yh  b(h )i i if(yFx ,z ;a,m,f,g,P) p exp  c(y ,f) ,i F,i i i[ ]a(f)
where
m′ ′ ′ ′h p x b  z g p x B(P)A  z g ,i C,i C i F,i i[ ]a
and f is the dispersion parameter (see table 1 of Schaid et al.
[2002]). Let denote the vector of the nuisance parametersz
( ). The likelihood function for on the basis of them,g,f,P (a,z)
data is(Y,G,Z)
n
L(a,z;Y,G,Z) p f(y ,x ,g dz ; a,z)  i F,i i i{ }
ip1 xF,i
n
p f(y dx ,z ;a,z)# P(g dx )# P(x ;P) .  i F,i i i F,i F,i{ }
ip1 xF,i
(4)
Because is an indicator function of whether the hap-P(gFx )i F,i
lotype count is compatible with the observed genotype ,x gF,i i
likelihood (4) can be further simpliﬁed as
n
L(a,z;Y,G,Z) p f(y dx ,z ;a,z)# P(x ;P) . (5)  i F,i i F,i{ }
ip1 x gF,i i
The score function for is the partial derivative of likelihooda
(5), with respect to . The resulting score statistic, denoted bya
, is the score function evaluated at the restricted maximum-Sa
likelihood estimates under the null hypothesis. is the statisticSa
we use to test haplotype effect; in appendix A, we show the
following result:
n ¯y  yi ′S p B(P) E(X dg )F ,a 0 i ia(f)ip1
˜apap0
˜zpz
where and are the restricted maximum-likelihood esti-˜a˜ z
mates under the null hypothesis, is the matrix with′B(P) B(P)0
the ﬁrst column (i.e., the baseline haplotype) removed, and
is the same as that deﬁned by Schaid et al. (2002),E(X dg )i i
the expected haplotype counts given the observed genotypes.
We see that the proposed score statistic that accounts for phase
and clustering ambiguities is the original score test of Schaid
et al. (2002) multiplied by the function of allocation matrix
.B(P)
To construct the test for haplotype-trait association that ad-
justs for environmental covariates, we need the variance of
. We consider the generalized score test, which would ensureSa
the asymptotic null distribution even under model misspe-2x
ciﬁcation (Boos 1992). Deﬁne and let denote theV p (a,z) Va
variance of . As indicated by Boos (1992),Sa
1 ′ 1 ′V p (D  I I D D I Ia aa az zz az az zz az





D Daa az ′D p p s (y ,g ,z ,V)s (y ,g ,z ,V)′ i i i i i i i i( )D D ip1az zz
n
s (y ,g ,z ,V)I I i i i iaa azI p p  E .′( ) [ ]′I I Vip1az zz
The individual score function

s (y ,g ,z ,V) { logL(V; y ,g ,z )i i i i i i i
V
is the ﬁrst derivative of the log likelihood with respect to ,V
and matrix is the expected Fisher information.We use a hybridI
method to estimate —that is, to replace the nonzero elementsI
of by the observed Fisher information (Kent 1982; BoosI
1992).
In appendix B, we list the nonzero entries of matrices andD
that are in . As in the work of Schaid et al. (2002), hereI Va
we also see that the score function for and the score functiona
for P are independent under the null hypothesis; that is, the
covariance between the two score functions is zero. Hence,
although the estimate of the haplotype frequency P is required
in calculating the score statistic , the variance of the scoreSa
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statistic is not penalized by the use of estimated haplotype
frequencies.
Finally, we assemble and into the score test for assessingS Va a
the global and haplotype-speciﬁc association. The global score-
test statistic for testing is . Under the null′ 1a p 0 T { S V Sg a a a
hypothesis of no haplotype association, follows a dis-2T xg
tribution with df. The haplotype-speciﬁc test for haplotype∗L
h can be conducted via the test statistic ,2T p S /Diag(V )h a(h) a (h)
where the subscript indicates the hth element of a vector.(h)
The statistic follows under the null hypothesis2T x H :a ph 1 0 h
.0
Beneﬁting from the R functions developed by Schaid et al.
(2002), we implemented the proposed score test in R that is




Simulation studies are conducted to evaluate the power
and type I error of association tests on the basis of the
clustered haplotypes. The haplotype data are generated
in a way similar to that of Roeder et al. (2005) and
Tzeng (2005). We simulate 100 SNP haplotypes, using
a modiﬁed Hudson’s (Hudson 2002) MS program (Wall
and Pritchard 2003). This program generates data under
a coalescent model in which the recombination rate var-
ies across the SNP sequence. The scaled recombination
rate, , is set to range from to3r p 4N d/bp 4 # 10e
for the recombination cold spots, with38 # 10 1 #
as the effective population size . In the hot spots,410 Ne
r is set to be 45 times greater than the rate in the cold
spots. The recombination parameters are chosen tomimic
the linkage disequilibrium (LD) patterns of the SELP
gene shown in the SeattleSNP database. The scaled mu-
tation rate for the entire region, , is set to be4N m/bpe
. The rate is chosen to produce the number45.6 # 10
of common SNPs (per kb) in the European American
sample from the SeattleSNP database. Examining the
matrix plots of pairwise correlations ( ) between SNPs,2R
we see that the original gene data and the simulated
haplotype sequences have similar LD patterns and con-
sist of three major blocks. Such a blocky setting allows
us to evaluate the grouping method when applying to
regions with reduced haplotype diversity.
We discard rare SNPs so that the minor-allele frequen-
cies are 10.05. We then determine the liability locus ac-
cording to the frequency of the liability allele, q, and the
location of the locus. We consider three possible fre-
quencies: , 0.3, or 0.5. The positions—that is,q p 0.1
whether a liability locus exists in a haplotype block or
recombination hot spot—are determined by the entropy-
based blocking algorithm of Rinaldo et al. (2005). Once
a liability locus is chosen, a haplotype is deﬁned as a
segment of six adjacent SNPs in which the third SNP is
the liability locus. We sample 400 haplotypes with re-
placement from the 100 6-SNP haplotypes, randomly pair
them to form 200 individuals, and then determine their
phenotypes according to the genotypes at the liability
locus. This process is repeated 1,000 times to obtain
1,000 data sets.
Now we describe how the phenotypes are determined.
Assuming an additive effect of the liability allele, we gen-
erate both continuous and binary trait values. We use
random sampling for continuous traits and balanced case-
control sampling for binary traits, as done by Lake et
al. (2003). To mimic a complex disease of a single lia-
bility allele with moderate effect, the phenotypes are de-
termined using methods described below.
Continuous traits.—Here, we consider two simple
models of quantitative traits. The ﬁrst model (model I)
decomposes the trait value into genetic effect g and envi-
ronmental effect e: . The second model (modelY p g e
II) additionally incorporates a covariate Z: Y p g
. In both models, g has a discrete distribution,g # Z e
where g equals , , and with probabilities ,2u u u q2 1 0
, and , respectively; e follows a normal22q(1 q) (1 q)
distribution with mean e and variance . In the second2je
model, Z is generated from a standard normal distribu-
tion. For simplicity, we set , , andu p j 1 e p 0 g pj
. The trait values are generated using the normal pen-1
etrance function for the ﬁrst model2f(Y d j) p N(u ,j )j e
and for the second model.2f(Y d j) p N(u  g # Z,j )j e
We determine through the heritability of the liability2je
locus , which is deﬁned as2h
2jg2h p .2 2j  jg e
With simple algebra, we set the environmental variance
to
2 21 h 1 h2 2j p j # p 2q(1 q) # .e g 2 2h h
We set so that the average power of the full-2h p 0.1
dimensional regression analysis is ∼0.5 at nominal level
0.01 for a sample with 200 individuals.
Binary Traits.—We generate phenotypes on the basis
of a penetrance function , with which an individual wasfj
assigned “affected” status with probability if he/shefj
possesses j copies of liability alleles. If for affectedY p 1
and for unaffected, then . DeﬁneY p 0 f { P(Y p 1 d j)j
r to be the relative ratio and K the prevalence. Givenf /f1 0
r, K, and the liability-allele frequency q, we have f p0
, , and under anK/(1 2q 2qr) f p rf f p 2rf  f1 0 2 0 0
additive model. Here, we set and . Tor p 2 K p 0.01
perform a case-control sampling, two samples are drawn
with replacements from the 100 6-SNP haplotypes and
are paired to form an individual. Then the individual
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Table 1




Fit I Fit IIa Fit IIb Fit III
a p .05 a p .01 a p .05 a p .01 a p .05 a p .01 a p .05 a p .01
High:
q p .1 .042 .006 .048 .006 .048 .012 .050 .007
q p .3 .032 .002 .028 .002 .040 .002 .039 .010
q p .5 .038 .010 .042 .006 .036 .004 .042 .007
Moderate:
q p .1 .044 .012 .048 .006 .046 .004 .052 .012
q p .3 .050 .008 .036 .006 .034 .016 .042 .013
q p .5 .046 .012 .034 .002 .024 .002 .046 .011
Low:
q p .1 .044 .008 .042 .008 .040 .002 .052 .008
q p .3 .044 .006 .046 .008 .036 .008 .032 .002
q p .5 .048 .010 .036 .002 .028 .002 .046 .008
with j copies of liability alleles is assigned to be a case
if a randomly selected number is less than and other-fj
wise is assigned to be a control. This process is repeated
until we obtain 100 cases and 100 controls.
Results
Haplotypes and trait values are generated under nine
scenarios, according to the frequency of the disease allele
( 0.1, 0.3, or 0.5) and the diversity (high, moderate,q p
or low) of the haplotype where the disease locus exists.
“High diversity” indicates that a disease locus is located
in the region of recombination hot spots and that the
number of distinct haplotypes is 10–16; “moderate di-
versity” indicates that a disease locus is located in a
haplotype block and that the number of distinct haplo-
types is 9–12; “low diversity” indicates that a disease
locus is located in a haplotype block and that the number
of distinct haplotypes is 5–8. The number of haplotypes
for the simulated data set has a range of 5–16; the pro-
posed method tends to retain 4–12 haplotype groups in
the analysis.
To study the performance of the proposed method in
detecting association, we calculate type I error and power
of the clustered score test on the basis of 1,000 simu-
lations. The P values are determined asymptotically by
the distribution. We also compared the test results2x
with the full dimensional analysis, in which the P values
are obtained via permutation test. In evaluating the test
performance, we consider the following ﬁts in each sim-
ulation; for model I, we ﬁt a regression model without
the covariate Z (ﬁt I); for model II, we ﬁt a regression
model both with (ﬁt IIa) and without (ﬁt IIb) the co-
variate; for the binary traits, we ﬁt a model without co-
variate (ﬁt III).
Table 1 displays the type I error of the global test with
use of the proposed method. The values in table 1 are
all near the nominal level a for either or 0.01,a p 0.05
indicating that the distribution adequately approxi-2x
mates the null distribution of the clustered score statis-
tics. The power of the global test is shown in ﬁgures 1
( ) and 2 ( ). In each ﬁgure, the foura p 0.05 a p 0.01
plots correspond to four ﬁts. Fit I and ﬁt IIa have similar
patterns, as one would expect. Once the covariate effect
is removed from ﬁt IIa, we see similar testing power. Fit
IIb does not take into account covariates that should
have been modeled, and we see a drop in the power. For
each scenario, the power of the clustered score statistics
tends to be above the power of the full-dimensional anal-
ysis. This suggests that the clustering approach with as-
ymptotic P values retains the same or higher power2x
than the full-dimensional test.
To explore the inﬂuence of the sample size, we double
the sample size and examine the power for .a p 0.05
For a continuous trait, because of our choice of herit-
ability, the power is almost 1 for both clustering and
full-dimensional methods for all the ﬁts. Nevertheless,
we can still observe the effect of the sample size through
a binary trait. As shown in ﬁgure 1, panel ﬁt III (dis-
played in red), although the power of both methods
moves up when sample size is doubled, the relative re-
lationship between the power of the two methods re-
mains roughly similar.
Next, we examine the signiﬁcant causal haplotypes
identiﬁed by the clustered approach and by the full-di-
mensional approach in the global test. We deﬁned the
difference count, which equals k if there are k haplotypes
identiﬁed by the full-dimensional method but not by the
clustered method and which equals for the reversek
situation. The difference counts across the nine scenarios
are recorded and the histograms of ﬁt I and ﬁt III are
presented in ﬁgure 3. Among the simulated data sets,
∼75% of the data contain three causal haplotypes, and
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Figure 1 Power of the global score test with the nominal level
and sample size individuals, obtained via 1,000a p 0.05 n p 200
simulations. The blue C indicates the power of the clustered score test,
and the black F indicates the power of the full-dimensional score test.
Along the X-axis, H p high haplotype diversity, M p moderate hap-
lotype diversity, L p low haplotype diversity, 1 p allele frequency
0.1, 2 p allele frequency 0.3, and 3 p allele frequency 0.5. In the Fit
III plot, the results presented in red are the power for doubling the
sample size n to 400 individuals.
Figure 2 Power of the global score test with the nominal level
and sample size individuals, obtained via 1,000a p 0.01 n p 200
simulations. The blue C indicates the power of the clustered score test,
and the black F indicates the power of the full-dimensional score test.
Along the X-axis, H p high haplotype diversity, M p moderate hap-
lotype diversity, L p low haplotype diversity, 1 p allele frequency
0.1, 2 p allele frequency 0.3, and 3 p allele frequency 0.5.
25% of them contain four causal haplotypes. Whenmis-
detection occurs, the clustered approach tends to miss
one or two causal haplotypes, although it misses three
occasionally (the probability is very close to 0, as shown
in the histogram plot). Once in a while (∼8%), the clus-
tered approach detects extra causal haplotypes that are
not identiﬁed by the full-dimensional method, but most
of the time (∼80%) the clustered test detects the same
haplotypes as does the full-dimensional test.
Finally, we studied the power and type I error of the
haplotype-speciﬁc test. The results are displayed in table
2. The trait values are generated in the same way as de-
scribed above, except that here we predetermine a causal
haplotype instead of a causal SNP. We set the frequency
of the causal haplotype to 0.1 and consider the haplotype
diversity to be low or high. We also consider the scenario
of common haplotype frequency (0.4) in a low-diversity
setting, which allows us to assess the performance of the
clustering method in the least-favorable setting. From
table 2, we see that the type I error rates of the haplotype-
speciﬁc test are around the nominal level. When the
causal haplotype is rare in the population (i.e., 0.1), we
see power improvement by the clustered score test com-
pared with the full-dimensional test. The power values
of the clustered tests are similar to the full-dimensional
analysis for a common causal haplotype with a limited
haplotype diversity.
Data Application to the Hypertriglyceridemia Study
We applied the proposed method to the study of hyper-
triglyceridemia conducted at the National Taiwan Uni-
versity Hospital. Hypertriglyceridemia, the elevation of
plasma triglyceride concentrations, is a common meta-
bolic disorder in the general population, and its corre-
lation with the risk of cardiovascular diseases remains
a subject of enormous attention (Assmann et al. 1996;
Gaziano et al. 1997; Jeppesen et al. 1998; Cullen 2000).
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Figure 3 Histogram of difference count: the difference of num-
ber of signiﬁcant haplotypes identiﬁed by the full-dimensional analysis
and identiﬁed by the clustered analysis in the global score test. The
Y-axis indicates the relative frequency.
Recent research has suggested the association of the var-
iations in the apolipoprotein C-III gene with the differ-
ences in triglyceride levels (Ordovas et al. 1991; Peacock
et al. 1994; Waterworth et al. 2000, 2001). One main
objective of the present study was to investigate the role
of genetic polymorphisms in the apolipoprotein C-III
gene in hypertriglyceridemia susceptibility.
The present study recruited 290 affected individuals
whose serum triglyceride levels were 1400 mg/dl and 303
healthy individuals as controls. The controls were re-
cruited through health examinations conducted in the
National Taiwan University Hospital. The exclusion cri-
teria were secondary hyperlipoproteinemia, hyperten-
sion, diabetes mellitus, medications of lipid-lowering
agents, and endocrine or metabolic disorders. All sub-
jects were residents of Taiwan and provided signed in-
formed consent before participating in the study. The
study protocol was approved by theMedical Ethics Com-
mittee of National Taiwan University Hospital. DNA
samples from both the case and control subjects were
extracted and were ampliﬁed by the PCR technique in
a GeneAmpR PCR System (Applied Biosystems Division
of Perkin-Elmer).
In particular, Kao et al. (2003) studied APOA5 on
chromosome 11q23 and identiﬁed novel variants in this
gene region. As a proof check of the proposed method,
we applied the proposed score test on the same APOA5
data set. The polymorphic sites considered in APOA5
include IVS3476, c.457, c.553, c.1177, and c.1259;
these ﬁve SNPs compose the haplotypes in the analysis.
We incorporated three environmental covariates—age,
sex, and BMI—in the regression model and used the
continuous triglyceride level as the dependent variable.
We also performed the analysis, using the dichotomized
trait values with for serum triglyceride 1400 mg/Y p 1
dl and otherwise. The results of both trait typesY p 0
were similar.
The expectation-maximization algorithm was used to
reconstruct 14 distinct haplotypes from the 5-locus ge-
notypes. In the haplotype-clustering regression, we ob-
tained four haplotype groups, represented by GGGCT,
GGTCT, AGGCC, and GAGTT, in which these four
most-frequent haplotypes explained 95.8% of the total
haplotype variation. The global score-test statistic has 3
df and is highly signiﬁcant (66.78 for the continuous
trait and 95.28 for the binary trait; both P values are
). The ﬁrst three haplotypes were found to be6! 1 # 10
signiﬁcant. The haplotype-speciﬁc score statistics (P val-
ues) are 64.16 ( ), 38.94 ( ), and6 6! 1 # 10 ! 1 # 10
7.62 ( ) for the continuous trait and 86.86 (.0058 ! 1 #
), 58.06 ( ), and 20.43 ( ) for6 6 610 ! 1 # 10 6 # 10
the binary trait. Among these haplotypes, haplotypes
GGTCT and AGGCC were shown elsewhere to be as-
sociated with increased plasma triglyceride concentra-
tion (Pennacchio et al. 2001; Kao et al. 2003). The
full-dimensional score test of Schaid et al. (2002) also
identiﬁed the same three haplotypes to be signiﬁcantly
associated with triglyceride level. The score statistics
(and P values) of the haplotype-speciﬁc test are 64.64
( ), 90.25 ( ), and 8.35 (.0038) for6 6! 1 # 10 ! 1 # 10
GGGCT, GGTCT, and AGGCC, respectively.
Discussion
Haplotype analyses will likely continue to play an impor-
tant role in studying common complex diseases (Schaid
2004). Haplotypes effectively capture the joint marker
correlation and the evolutionary history; the progressive
knowledge of the haplotype structure holds great prom-
ise for the use of haplotype information to understand
genetic risk factors (International HapMap Consortium
2003). However, naive haplotype analyses can lead to
limited performance, since they require many degrees of
freedom (Schaid 2004), many of which are expended
on rare haplotypes (Chapman et al. 2003). To fully re-
alize the potential of haplotype analyses, new haplotype-
based methods are needed—methods that do not dilute
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Table 2






POWER AND TYPE I ERROR















q p .1 .778 .984 .046 .758 .952 .006
Low diversity:
q p .1 .910 .990 .046 .862 .958 .012
q p .4 .998 .998 .054 .984 .986 .010
Fit III:
High diversity:
q p .1 .438 .666 .045 .296 .424 .010
Low diversity:
q p .1 .500 .642 .042 .270 .386 .007
q p .4 .768 .786 .052 .524 .544 .007
their power to detect interesting gene-trait relationships
among many distinct haplotypes.
In the present study, we introduce one such test for
assessing haplotype-phenotype association. To overcome
the degrees-of-freedom problem, our strategy is to an-
alyze groups of homogeneous haplotypes within which
haplotypes share similar effects on phenotypes. The pro-
posed method uses unphased genotypes and provides
several advantages in performing haplotype analyses. It
offers an integrated procedure for haplotype analysis, in-
cluding phase reconstruction, haplotype clustering, and
inference of haplotype effects. By combining the merits
of the GLM score test of Schaid et al. (2002) and the
probabilistic clustering technique of Tzeng (2005), the
proposed approach incorporates uncertainties that arise
from missing haplotype phase and unknown haplotype
tree in the assessment of haplotype-phenotype associa-
tion. The method is constructed under a model-based
framework; hence, it can accommodate a wide range of
trait values. It allows simultaneous consideration of the
multiple environmental and genetic factors that underlie
complex traits. It can also be used to evaluate either the
overall haplotype association or the individual haplotype
effects. Simulation results show that the clustered score
test has correct type I error rates and can improve power
to detect association at either the global or haplotype-
speciﬁc level when compared with the full-dimensional
method.
The proposed method also has its limitations. Moti-
vated by the common disease/common variants hypoth-
esis, the clustered test is designed to identify common
polymorphisms with small or large effect. It is incapable
of detecting rare variants with large effect because rare
haplotypes are not retained in the clustered haplotype
space. Next, established on the Tzeng (2005) algorithm,
the proposed method also inherits its major assumption
that the haplotype diversity is due mainly to mutation;
other diversifying forces, such as recombination, are neg-
ligible in evolution. As a result, the proposed method
would be more appropriate to apply to tightly linked
DNA regions. Furthermore, unlike several proposed clus-
tering methods for ﬁne mapping (e.g., that of Molitor
et al. 2003a, 2003b), our method does not take into
account the location and/or order of the markers. For
example, if one permutes the SNPs and applies our clus-
tering algorithm, we would expect to get the same an-
swers. Thus, our method is more suitably applied for
studying haplotype association—such as the goal of can-
didate-gene studies—than for mapping purposes.
Finally, our method is derived on the basis of perspec-
tive likelihood, which can be less efﬁcient than retro-
spective approaches for case-control samples when hap-
lotypes have a nonmultiplicative effect on the disease
odds (Satten and Epstein 2004). In our simulation, we
also observed a less-signiﬁcant power gain in ﬁt III (case-
control data) when . However, our proposeda p 0.01
method is just one of many possible ways to integrate
regression methods with dimension-reduction techniques.
One of our key ﬁndings is the simple presentation of the
clustering algorithm through a linear transformation:
. This deduction offers a convenient path′ ′X p X B(P)C F
for extending our results to a wide range of regression-
based methods, including the retrospective method of
Epstein and Satten (2003). We plan our further research
along this path.
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Appendix A
Let denote the score function of the ob-S (Y,G,Z,a,z)a
served data for . As set forth by Louis (1982),(Y,G,Z) a
is the expectation of the complete-dataS (Y,G,Z,a,z)a
score function given the observed data—that is,
. Hence,S (Y,G,Z,a,z) p E [S (Y,X ,Z,a,z) dG]a a F
n
[ ]S (Y,G,Z,a,z) p E logL(a,z; y ,x ,z ) ga i F,i i iFaip1
n
[ ][ ]p E log f(yFx ,z ;a,z) log P(x ;P) g i F,i i F,i iFaip1
n ′y  b (h)i ′p E B(P) X d g 0 i i[ ]a(f)ip1
n y  E(y )i i ′p B(P) E(X d g ) . 0 i ia(f)ip1
Appendix B
Let . The expected Fisher information func-G p (m,g)
tion of the observed data , , is(Y,G,Z) I
I I I Iaa aG af aP
′I I I IaG GG Gf GPI p ,′ ′I I I I( )af Gf ff fP
′ ′ ′I I I IaP GP fP PP
where
I p 0 ,∗af L #1
I p 0 ,∗aP L #(L1)
I p 0 ,Gf (1P)#1
I p 0 .GP (1P)#(L1)
and
I p 0 .fP 1#(L1)
The hybrid estimate of is obtained by replacing theI
nonzero entries of with the observed Fisher informationI
(denoted by ):i
i i 0 0aa aG
′i i 0 0aG GGI p .
0 0 i 0( )ff
0 0 0 iPP
Hence, equation (6) can be simpliﬁed as
1 ′ 1 ′ 1 1 ′V p D  i i D D i i  i i D i i .a aa aG GG aG aG GG aG aG GG GG GG aG
Recall that
n
′D p s (y ,g ,z ,V)s (y ,g ,z ,V) i i i i i i i i
ip1
and that Louis (1982) proposed
[ ]s (y ,g ,z ,V) p E s (y ,x ,z ,V) d gi i i i i i F,i i i
and
n
s (y ,x ,z ,V)i i F,i ii p E  g [ ]iF{ Vip1
′E s (y ,x ,z ,V)s (y ,x ,z ,V) F g[ ]i i F,i i i i F,i i i
′[ ] [ ]E s (y ,x ,z ,V) d g E s (y ,x ,z ,V) d g .i i F,i i i i i F,i i i }
We have
n ′ 2y  b (h )i i ′ ′D p B(P) E(x Fg)E(x Fg)B(P) ,aa 0 F,i F,i 0( )a(f)ip1
n ′ 2y  b (h )i i ′ ′D p B(P) E(x Fg)[1 z ] ,aG 0 F,i i( )a(f)ip1
n ′ 2y  b (h ) 1i i ′D p [1 z ] ,GG i[ ]( ) za(f)ip1 i
n ′′b (h) ′ ′i p B(P) E(x Fg)[1 z ] ,aG 0 F,i ia(f)ip1
and
n ′′b (h) 1 ′i p [1 z ] .GG i[ ]za(f)ip1 i
Web Resources
The URL for data presented herein is as follows:
Authors’ Web site, http://www4.stat.ncsu.edu/˜tzeng/Softwares/
Hap-Clustering/R/ (for R codes for implementing the proposed test)
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